KYTHERA Announces Additional Positive Efficacy and Patient Satisfaction Data From ATX-101 Phase III Trials for the Reduction of Submental Fat
October 07, 2013 09:00 ET
|
KYTHERA Biopharmaceuticals, Inc.
CALABASAS, Calif., Oct. 7, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced additional patient satisfaction and efficacy data from REFINE-1 and REFINE-2, two...
KYTHERA Appoints F. Michael Ball to Board of Directors
September 19, 2013 16:10 ET
|
KYTHERA Biopharmaceuticals, Inc.
CALABASAS, Calif., Sept. 19, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced it has named F. Michael (Mike) Ball, Chief Executive Officer (CEO) of Hospira, Inc....
KYTHERA Announces Positive ATX-101 Top Line Phase III Trial Results for the Reduction of Submental Fat
September 16, 2013 17:26 ET
|
KYTHERA Biopharmaceuticals, Inc.
CALABASAS, Calif., Sept. 16, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that its ATX-101 REFINE-1 and REFINE-2 Phase III trials met all primary and...
KYTHERA Biopharmaceuticals Announces Second Quarter 2013 Operating Results
August 06, 2013 16:10 ET
|
KYTHERA Biopharmaceuticals, Inc.
LOS ANGELES, Aug. 6, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today reported financial results for its second quarter 2013, and provided an update on recent...
KYTHERA Biopharmaceuticals to Release Second Quarter 2013 Operating Results
July 23, 2013 20:30 ET
|
KYTHERA Biopharmaceuticals, Inc.
LOS ANGELES, July 23, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced it will release its second quarter 2013 operating results and will host an investor call...
KYTHERA Biopharmaceuticals to Present at Goldman Sachs 34th Annual Global Healthcare Conference
June 06, 2013 16:10 ET
|
KYTHERA Biopharmaceuticals, Inc.
LOS ANGELES, June 6, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that Keith Leonard, president and chief executive officer, will present at the Goldman...
KYTHERA Biopharmaceuticals Announces First Quarter 2013 Operating Results
May 13, 2013 16:10 ET
|
KYTHERA Biopharmaceuticals, Inc.
LOS ANGELES, May 13, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today reported financial results for its first quarter 2013, and provided an update on recent...
KYTHERA Biopharmaceuticals to Present at Bank of America Merrill Lynch 2013 Healthcare Conference
May 07, 2013 16:30 ET
|
KYTHERA Biopharmaceuticals, Inc.
LOS ANGELES, May 7, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that Keith Leonard, president and chief executive officer, will present at the Bank of...
KYTHERA Biopharmaceuticals to Release First Quarter 2013 Operating Results
May 02, 2013 16:57 ET
|
KYTHERA Biopharmaceuticals, Inc.
LOS ANGELES, May 2, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced it will release its first quarter 2013 operating results and will host an investor call and...